Our CTO, Hiroki Makiguchi, Takes the Stage at BioJapan-Hosted Seminar: “The AI Revolution in Drug Discovery”
November 18, 2024
On October 11, our CTO (Hiroki Makiguchi) spoke at the BioJapan-hosted seminar, “The AI Drug Discovery Revolution.”
Presentation Title: “Transforming the Future of Drug Discovery with AI and Supercomputing: Cutting-Edge Efforts at Tokyo-1”
AI not only reduces the enormous costs and time associated with research, development, and clinical trials, but it is also becoming an indispensable tool for increasing the success rates of innovative new drug development. Our CTO, Hiroki Makiguchi, shared insights on how AI and supercomputers are driving innovation in drug discovery research, as well as the latest initiatives at our drug discovery innovation hub, Tokyo-1.
For more details, please refer to the following link:
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN